Kerry M Leehan1, Nathan P Pezant2, Astrid Rasmussen2, Kiely Grundahl2, Jacen S Moore2, Lida Radfar3, David M Lewis3, Donald U Stone4, Christopher J Lessard1, Nelson L Rhodus5, Barbara M Segal6, R Hal Scofield7, Kathy L Sivils1, Courtney Montgomery2, A Darise Farris8. 1. Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation (OMRF); Department of Pathology, University of Oklahoma Health Sciences Center (OUHSC), Oklahoma City, OK, USA. 2. Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation (OMRF), Oklahoma City, OK, USA. 3. College of Dentistry, University of Oklahoma Health Sciences Center (OUHSC), Oklahoma City, OK, USA. 4. Department of Ophthalmology, Johns Hopkins University, Baltimore, MD,USA; and King Khaled Eye Specialist Hospital, Riyadh, KSA. 5. Division of Oral Medicine and Diagnosis, Department of Diagnostic and Biological Sciences, School of Dentistry, University of Minnesota, MN, USA. 6. Division of Rheumatic and Autoimmune Diseases, University of Minnesota, MN, USA. 7. Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation; Department of Medicine, University of Oklahoma Health Sciences Center; Department of Veteran's Affairs Medical Center, Oklahoma City, OK, USA. 8. Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation (OMRF); Department of Pathology, University of Oklahoma Health Sciences Center (OUHSC), Oklahoma City, OK, USA. farrisd@omrf.org.
Abstract
OBJECTIVES: Evaluate the presence of minor salivary gland (SG) fibrosis in primary Sjögren's syndrome (pSS) as a function of disease pathology or a consequence of ageing. METHODS: Subjects with sicca symptoms attending a Sjögren's research clinic were classified by American European Consensus Group (AECG) criteria as either pSS or non-SS (nSS). Discovery (n=34 pSS, n=28 nSS) and replication (n=35 pSS, n=31 nSS) datasets were evaluated. Minor SG cross-sections from haematoxylin and eosin stained slides were imaged, digitally reconstructed and analysed for percent area fibrosis. Relationships between SG fibrosis, age, and clinical measures were evaluated using Spearman correlations. Association with SS was assessed by: ROC curve, Variable Selection Using Random Forests (VSURF) and uni- and bi-variate regression analyses. RESULTS: SS subjects had significantly more fibrotic tissue in their minor labial salivary glands (median 24.39%, range 5.12-51.67%) than nSS participants (median 16.7%, range 5.97-38.65%, p<0.0001); age did not differ between groups (average ± SD pSS 50.2 ±13.9 years, nSS 53.8±12.4 years). In both the discovery and replication data sets, multiple regression models showed that the area of minor salivary gland fibrosis predicted pSS significantly better than age alone. Age-corrected linear regression revealed that the area of minor salivary gland fibrosis positively associated with vanBijsterveld score (p=0.042) and biopsy focus score (p=0.002). ROC curve and VSURF analyses ranked fibrosis as a significantly more important variable for subject discrimination than age. CONCLUSIONS: SG fibrosis is an element of pSS pathology that is related to focus score and is not solely attributable to age.
OBJECTIVES: Evaluate the presence of minor salivary gland (SG) fibrosis in primary Sjögren's syndrome (pSS) as a function of disease pathology or a consequence of ageing. METHODS: Subjects with sicca symptoms attending a Sjögren's research clinic were classified by American European Consensus Group (AECG) criteria as either pSS or non-SS (nSS). Discovery (n=34 pSS, n=28 nSS) and replication (n=35 pSS, n=31 nSS) datasets were evaluated. Minor SG cross-sections from haematoxylin and eosin stained slides were imaged, digitally reconstructed and analysed for percent area fibrosis. Relationships between SG fibrosis, age, and clinical measures were evaluated using Spearman correlations. Association with SS was assessed by: ROC curve, Variable Selection Using Random Forests (VSURF) and uni- and bi-variate regression analyses. RESULTS: SS subjects had significantly more fibrotic tissue in their minor labial salivary glands (median 24.39%, range 5.12-51.67%) than nSSparticipants (median 16.7%, range 5.97-38.65%, p<0.0001); age did not differ between groups (average ± SD pSS 50.2 ±13.9 years, nSS 53.8±12.4 years). In both the discovery and replication data sets, multiple regression models showed that the area of minor salivary gland fibrosis predicted pSS significantly better than age alone. Age-corrected linear regression revealed that the area of minor salivary gland fibrosis positively associated with vanBijsterveld score (p=0.042) and biopsy focus score (p=0.002). ROC curve and VSURF analyses ranked fibrosis as a significantly more important variable for subject discrimination than age. CONCLUSIONS: SG fibrosis is an element of pSS pathology that is related to focus score and is not solely attributable to age.
Authors: C Vitali; S Bombardieri; H M Moutsopoulos; G Balestrieri; W Bencivelli; R M Bernstein; K B Bjerrum; S Braga; J Coll; S de Vita Journal: Arthritis Rheum Date: 1993-03
Authors: Astrid Rasmussen; John A Ice; He Li; Kiely Grundahl; Jennifer A Kelly; Lida Radfar; Donald U Stone; Kimberly S Hefner; Juan-Manuel Anaya; Michael Rohrer; Rajaram Gopalakrishnan; Glen D Houston; David M Lewis; James Chodosh; John B Harley; Pamela Hughes; Jacen S Maier-Moore; Courtney G Montgomery; Nelson L Rhodus; A Darise Farris; Barbara M Segal; Roland Jonsson; Christopher J Lessard; R Hal Scofield; Kathy L Moser Sivils Journal: Ann Rheum Dis Date: 2013-08-22 Impact factor: 19.103
Authors: Leyla Y Teos; Yu Zhang; Ana P Cotrim; William Swaim; Jon H Won; Julian Ambrus; Long Shen; Lolita Bebris; Margaret Grisius; Shyh-Ing Jang; David I Yule; Indu S Ambudkar; Ilias Alevizos Journal: Sci Rep Date: 2015-09-14 Impact factor: 4.379
Authors: K J O'Keefe; K A DeSantis; A L Altrieth; D A Nelson; E Z M Taroc; A R Stabell; M T Pham; M Larsen Journal: J Dent Res Date: 2019-11-25 Impact factor: 6.116
Authors: Kerry M Leehan; Nathan P Pezant; Astrid Rasmussen; Kiely Grundahl; Jacen S Moore; Lida Radfar; David M Lewis; Donald U Stone; Christopher J Lessard; Nelson L Rhodus; Barbara M Segal; C Erick Kaufman; R Hal Scofield; Kathy L Sivils; Courtney Montgomery; A Darise Farris Journal: Autoimmunity Date: 2017-10-08 Impact factor: 2.815
Authors: Agata Sebastian; Maciej Sebastian; Maria Misterska-Skóra; Patryk Woytala; Katarzyna Jakuszko; Piotr Wiland Journal: J Immunol Res Date: 2018-05-02 Impact factor: 4.818
Authors: Kimberly J Jasmer; Lucas T Woods; Kevin Muñoz Forti; Adam L Martin; Jean M Camden; Marco Colonna; Gary A Weisman Journal: Arch Oral Biol Date: 2021-02-03 Impact factor: 2.633
Authors: Gwenny M Verstappen; Lu Gao; Sarah Pringle; Erlin A Haacke; Bert van der Vegt; Silvia C Liefers; Vishal Patel; Yanhua Hu; Sumanta Mukherjee; Julie Carman; Laurence C Menard; Frederik K L Spijkervet; Arjan Vissink; Hendrika Bootsma; Frans G M Kroese Journal: Front Immunol Date: 2021-07-06 Impact factor: 7.561